T60654 |
KDM4C-IN-1
|
52348-60-4
|
99.33%
|
|
KDM4C-IN-1 is a selective and potent KDM4C inhibitor (IC50: 8 nM) with potential anticancer activity.KDM4C-IN-1 inhibits the growth of HepG2 and A549 cells, and ...
|
T24131 |
HDAC3-IN-T247
|
1451042-18-4
|
98.94%
|
|
HDAC3-IN-T247 (HDAC3 inhibitor T247) is a selective and potent histone deacetylase 3 (HDAC3) inhibitor with anticancer and antiviral activities.HDAC3-IN-T247 ind...
|
T39989 |
JQKD82
|
2410512-38-6
|
100.00%
|
|
JQKD82 is a selective inhibitor of KDM5 and increases H3K4me3. JQKD82 can be used in studies about the treatment of multiple myeloma.
|
T3677 |
GSK2879552
|
1401966-69-5
|
|
|
GSK2879552 is a selective, orally bioavailable, irreversible, mechanism-based inactivator of lysine-specific demethylase 1 (LSD1)/corepressor, with potential ant...
|
T35338 |
CP2
|
|
98%
|
|
CP2 is a useful organic compound for research related to life sciences and the catalog number is T35338.
|
T13057 |
T-448
|
1597426-53-3
|
98%
|
|
T-448 is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM).
|
T78577 |
NCD38 TFA
|
|
98%
|
|
NCD38 TFA serves as a selective inhibitor of LSD1 [1] [2].
|
T78888 |
LSD1-UM-109
|
2252446-26-5
|
98%
|
|
LSD1-UM-109 is a highly potent and reversible inhibitor of LSD1, demonstrating an IC50 of 3.1 nM. This compound exhibits strong antiproliferative activity, inhib...
|
T82254 |
GSK-LSD1
|
1431368-48-7
|
98%
|
|
GSK-LSD1, an LSD1 inhibitor, decreases food consumption and body weight while enhancing insulin sensitivity and glycemic regulation in murine obesity models. Add...
|
T12701 |
(rel)-Tranylcypromine D5 hydrochloride
|
107077-98-5
|
98%
|
|
(rel)-Tranylcypromine D5 hydrochloride is a deuterium labeled (rel)-Tranylcypromine hydrochloride. (rel)-Tranylcypromine hydrochloride is an irreversible, nonsel...
|
T22299 |
CPI-455 HCl
|
2095432-28-1
|
98%
|
|
CPI-455 is a specific KDM5 inhibitor with IC50 value of 10 ± 1 nM for full-length KDM5A in enzymatic assays, elevating global levels of H3K4 trimethylation (H3K...
|
T17278 |
YUKA1
|
708991-09-7
|
98%
|
|
YUKA1 is a potent and cell-permeable Lysine demethylase 5A inhibitor (IC50: 2.66 μM) and less active on KDM5C (IC50, 7.12 μM). YUKA1 is inactive on KDM5B, KDM6A,...
|
T11755 |
KF 13218
|
127654-03-9
|
98%
|
|
KF 13218 is a selective, potent and long lasting thromboxane B2 (TXB2) synthase inhibitor with an IC50 value of 5.3±1.3 nM.
|
T74855 |
LSD1-IN-25
|
2911585-60-7
|
98%
|
|
LSD1-IN-25 (Compound 9j) is a potent, selective, and orally active inhibitor of LSD1, exhibiting an IC50 of 46 nM (Ki = 30.3 nM) and capable of inducing apoptosi...
|
T13052 |
S2101
|
1239262-36-2
|
98%
|
|
S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s).
|
T11475 |
GSK-J1 lithium salt
|
2309668-29-7
|
98%
|
|
GSK-J1 lithium salt is an effective inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with an IC 50 of 60 nM for KDM6B.
|
T13056 |
T-448 free base
|
1597426-52-2
|
98%
|
|
T-448 free base is a specific, orally active and irreversible lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) inhibitor(IC50 of 22 nM).
|
T16700 |
QC6352
|
1851373-36-8
|
98%
|
|
QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM).
|
T11881 |
LSD1-IN-6
|
2035912-43-5
|
98%
|
|
LSD1-IN-6 increases dimethylated Lys4 of histone H3, shows no effect on expression of LSD1. LSD1-IN-6 is a potent and reversible inhibitor of lysine-specific dem...
|
T11503 |
GSK 690 Hydrochloride
|
2436760-79-9
|
98%
|
|
GSK 690 (Hydrochloride) is a reversible lysine specific demethylase 1 (LSD1) inhibitor with a Kd value of 9 nM and IC 50 of 37 nM.
|